Library
On this page you can find relevant researchs on drug-related health topics, including HIV, hepatitis C, drug and overdose prevention, harm reduction and drug treatment. You can also find our Clinical Guidelines.
Developing a Modified Directly Observed Therapy Intervention for Hepatitis C Treatment in a Methadone Maintenance Program: Implications for Program Replication
Hepatitis C virus (HCV) is a prevalent chronic blood-borne infection among opioid-dependent patients on methadone maintenance treatment (MMT). Despite case reports and case–control studies, a randomized controlled trial (RCT) examining HCV treatment adherence in methadone-maintained patients is lacking and was the impetus for this ongoing RCT examining modified directly administered therapy for HCV treatment integrated within a MMT.
Hepatitis C virus (HCV) is a prevalent chronic blood-borne infection among opioid-dependent patients on methadone maintenance treatment (MMT). Despite case reports and case–control studies, a randomized controlled trial (RCT) examining HCV treatment adherence in methadone-maintained patients is lacking and was the impetus for this ongoing RCT examining modified directly administered therapy for HCV treatment integrated within a MMT.
HIV, drug use and the Global Fund: Don’t Stop Now!
International HIV/AIDS Alliance demonstrate that a crisis in the Global Fund is a crisis for harm reduction, as the Global Fund has become the largest funder of global HIV and harm reduction programmes targeting people who use drugs. The report includes a set of recommendations, most prominent of which is a call to the Global Fund to ensure that it continues to support HIV and harm reduction programmes, so that global commitments to reduce HIV transmission of HIV among people who inject drugs by 50% by 2015 can be met.
International HIV/AIDS Alliance demonstrate that a crisis in the Global Fund is a crisis for harm reduction, as the Global Fund has become the largest funder of global HIV and harm reduction programmes targeting people who use drugs. The report includes a set of recommendations, most prominent of which is a call to the Global Fund to ensure that it continues to support HIV and harm reduction programmes, so that global commitments to reduce HIV transmission of HIV among people who inject drugs by 50% by 2015 can be met.
The Global Fund to Fight AIDS, Tuberculosis and Malaria and Support for Middle Income Countries
The International HIV/AIDS Alliance urges the Global Fund Board to revoke the 55% rule immediately and therefore stop its application to existing grants, grant renewals and future new grants.
The International HIV/AIDS Alliance urges the Global Fund Board to revoke the 55% rule immediately and therefore stop its application to existing grants, grant renewals and future new grants.
Human Rights and Drugs - Volume II
International Centre on Human Rights and Drug Policy. Articles in this volume address coerced drug treatment, the Convention on the Rights of the Child, the INCB and ayahuasca, and the death penalty for drug in China. There are also two case summaries on the Canadian Supreme Court decision on Insite, and on the Irish Press Ombudsman decision against an Irish newspaper for hate speech against people who are drug dependent.
International Centre on Human Rights and Drug Policy. Articles in this volume address coerced drug treatment, the Convention on the Rights of the Child, the INCB and ayahuasca, and the death penalty for drug in China. There are also two case summaries on the Canadian Supreme Court decision on Insite, and on the Irish Press Ombudsman decision against an Irish newspaper for hate speech against people who are drug dependent.
EU Drugs Strategy Taking a Step in the Right Direction
International Doctors for Healthy Drug Policies (IDHDP) comment on the European Union Committee’s Twenty-Sixth Report, EU Drugs Strategy.
International Doctors for Healthy Drug Policies (IDHDP) comment on the European Union Committee’s Twenty-Sixth Report, EU Drugs Strategy.
Advisory Council on the Misuse of Drugs: Consideration of naloxone
The ACMD concludes that naloxone provision is an evidence-based intervention, which can save lives. Naloxone provision fits with other measures to promote recovery by encouraging drug users to engage with treatment services, and ultimately, keep them alive until they are in recovery. This report recommends actions for government to take to consider naloxone’s role in steps to make an impact on drug-related death rates.
The ACMD concludes that naloxone provision is an evidence-based intervention, which can save lives. Naloxone provision fits with other measures to promote recovery by encouraging drug users to engage with treatment services, and ultimately, keep them alive until they are in recovery. This report recommends actions for government to take to consider naloxone’s role in steps to make an impact on drug-related death rates.
Opiate Flows Through Northern Afghanistan and Central Asia - A Threat Assessment
UNODC Studies and Threat Analysis Section (STAS), Division for Policy Analysis and Public Affairs (DPA), in the framework of UNODC Trends Monitoring and Analysis Programme/Afghan Opiate Trade Project, with the collaboration of the UNODC Country Office in Afghanistan and the UNODC Regional Office for Central Asia.
UNODC Studies and Threat Analysis Section (STAS), Division for Policy Analysis and Public Affairs (DPA), in the framework of UNODC Trends Monitoring and Analysis Programme/Afghan Opiate Trade Project, with the collaboration of the UNODC Country Office in Afghanistan and the UNODC Regional Office for Central Asia.
EMCDDA trend report for the evaluation of the 2005–12 EU drugs strategy
This report was compiled as a supporting document for the evaluation of the 2005–12 EU drugs strategy and its two action plans: 2005–08 and 2009–12. It reviews the main trends and changes in the European drug situation and in the responses developed by the EU Member States. Four main areas are covered by the report: drug use and drug-related problems; drug supply; drug policies; and demand reduction interventions.
This report was compiled as a supporting document for the evaluation of the 2005–12 EU drugs strategy and its two action plans: 2005–08 and 2009–12. It reviews the main trends and changes in the European drug situation and in the responses developed by the EU Member States. Four main areas are covered by the report: drug use and drug-related problems; drug supply; drug policies; and demand reduction interventions.
The war against people who use drugs: the costs
EHRN aims to assess whether national funding allocated for drug-related measures achieves the goals of slowing down or reversing drug epidemics and protecting society from drug-related harms. The report draws on country costs assessments done in Georgia, Kyrgyzstan, Romania and Russia as well as analysis of data from other countries of the region, including Ukraine and Tajikistan.
EHRN aims to assess whether national funding allocated for drug-related measures achieves the goals of slowing down or reversing drug epidemics and protecting society from drug-related harms. The report draws on country costs assessments done in Georgia, Kyrgyzstan, Romania and Russia as well as analysis of data from other countries of the region, including Ukraine and Tajikistan.
Cause for Alarm: The Incarceration of Women for Drug Offences in Europe and Central Asia, and the need for Legislative and Sentencing Reform
Harm Reduction International is the first to calculate the total number of females in prisons on drug offences in Europe and Central Asia.
Harm Reduction International is the first to calculate the total number of females in prisons on drug offences in Europe and Central Asia.
